Susan Wyrick
2012
In 2012, Susan Wyrick earned a total compensation of $269.9K as Principal Accounting Officer and Vice President, Finance at OncoGenex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $43,013 |
|---|---|
| Option Awards | $56,092 |
| Salary | $107,917 |
| Stock Awards | $62,895 |
| Total | $269,917 |
Wyrick received $107.9K in salary, accounting for 40% of the total pay in 2012.
Wyrick also received $43K in non-equity incentive plan, $56.1K in option awards and $62.9K in stock awards.
Rankings
In 2012, Susan Wyrick's compensation ranked 10,362nd out of 11,487 executives tracked by ExecPay. In other words, Wyrick earned more than 9.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,362 out of 11,487 | 10th |
Division Manufacturing | 3,845 out of 4,253 | 10th |
Major group Chemicals And Allied Products | 1,072 out of 1,198 | 11th |
Industry group Drugs | 820 out of 920 | 11th |
Industry In Vitro and In Vivo Diagnostic Substances | 42 out of 47 | 11th |
Source: SEC filing on April 24, 2014.
Wyrick's colleagues
We found three more compensation records of executives who worked with Susan Wyrick at OncoGenex Pharmaceuticals in 2012.